Discontinued — last reported Q4 '23
International Flavors & Fragrances Health & Biosciences — Total Assets decreased by 2.4% to $10.67B in Q4 2023 compared to the prior quarter.
Growth in assets relative to revenue may indicate capital expansion, while a decline could signal divestitures or asset depreciation.
This metric represents the total economic resources controlled by the Health & Biosciences segment, including property,...
Standard balance sheet metric for segment-level reporting in large industrial or specialty chemical companies.
iff_segment_health_biosciences_assets| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $14.77B | $10.92B | $10.67B |
| QoQ Change | — | -26.1% | -2.4% |
| YoY Change | — | -26.1% | -2.4% |